• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

Surgeons and device reps – one rep’s comments

August 27, 2016 By SPINEMarketGroup

In a recent article (Cafepharma.com), it was discussed the findings of a recent study that examined the relationship between surgeons and device reps. The study, which was published in Plos one, found that reps were often an integral part of the surgical team. It also raised concerns about misaligned incentives and the possibility that reps’ relationships with surgeons could adversely affect both patient care and healthcare costs.

We interviewed a veteran medical device rep to get his opinion on the article and the rep’s role in the OR. The rep we spoke with has been in the industry for 15 years. There are some possible differences between our subject’s experience and the experience of those in the study.

While orthopedic surgeons were interviewed as part of the study, it is somewhat implied that the procedures were scheduled procedures. Our subject is a trauma implant rep, and so is involved in primarily unplanned or emergency procedures.Read Interview Cafepharma.com

Related Posts:

  • The Unsung Guardians of the OR
  • 5 reasons why taking device sales reps out of the OR…
  • The "Poverty Spirit"​ Device Rep

Filed Under: NEWS Tagged With: 2016, NEWS

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • BROCHURES
  • Globus Medical: Stronger in Spine, but Could DePuy…
  • PRODUCT LIBRARY
  • Who Is Really Winning the Mid-Tier Spine…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • Johnson & Johnson Explores Potential $20B Sale…
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • What Is Medtronic’s PILAR™ Technique?
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Globus Medical Reports Fourth Quarter and Full Year…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • From Niche to Momentum: The Rapid Rise of Spinal…
  • Single-Use Spine Surgery Systems: The Future or…
  • Behind the Deal: The Strategic Logic of Zavation’s…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • Expandable cages were adopted not because they fused…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • VB Spine Announces Successful First Clinical Cases…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • From Early Innovations to Modern Practice: Where Are…
  • VB Spine Announces VB Spine Solutions, a…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • ATEC’s Valence: Robotics in Service of a Procedural Strategy
  • Globus Medical Reports First Quarter 2026 Results
  • LAST 5 VIDEOS PUBLISHED

    1. REACH Medical: Expandable PLIF/TLIF Cage
    2. Expanding Innovations: X-PAC®TLIF 
    3. SI-BONE: iFuse INTRA Ti™ Implant System
    4. Globus Medical: IntraLIF™ Cannulated
    5. SI-BONE: iFuse TORQ TNT® Implant System

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup